Fundraising FoxRadar Ventures — Full Portfolio
22 tracked investments · listed companies and verified rows first
Physical AI for industrial automation
Renton, US
Minas Liarokapis(Executive Officer, Director)inPatrick Jarvis(Founder)inKonstantinos Stafylas(Executive Officer)
BoardAtlanta Daniels(Director)Nikos Kalliagkopoulous(Director)
Co-investorsBig Pi VenturesAether Ventures
AIM builds Fractl, a directed-energy counter-drone system that combines AI-enabled precision tracking with a high-power fibre laser to disable drones at ranges up to 1.5 km.
AI & Machine LearningDeep TechDefense TechMelbourne, AU
Capital 49 is a venture capital firm investing in fintech, AI infrastructure, and SaaS companies globally.
AI & Machine LearningEnterprise SoftwareFintechSaaS
Jack Zhang(CEO and co-founder of Airwallex)inChrisPhilipp
Co-investorsAbstract VenturesAthletic VenturesBattery VenturesBenchmarkEmergence Capital PartnersOpenAI Startup Fund+6 more
Contactile develops tactile sensor technology, including the PapillArray tactile sensor arrays that measure 3D displacement, force, vibration, torque, slip, and friction, along with force/torque sensors and two-finger grippers.
AI & Machine LearningDeep TechHardwareRoboticsSydney, AU
Heba Khamis(CEO, Co-founder)inBenjamin Xia(CTO, Co-founder)inStephen Redmond(Co-founder (2019-2022))
Co-investorsFlying Fox VenturesTrue VenturesUNSW Founders 10x
Cortical Labs develops biological computing systems by growing human neurons on chips to create a programmable computing platform.
AI & Machine LearningBiotechDeep TechMelbourne, AU
Co-investorsBlackbird FoundryBlackbird VenturesGobi PartnersHorizons VenturesLifeX VenturesIn-Q-Tel+1 more
Diag-Nose.io develops precision diagnostics and therapies for respiratory diseases including asthma, COPD, and sinusitis by combining nasal microsampling, proteomics, and machine learning to analyze airway biology.
AI & Machine LearningBiotechDigital HealthMedical Devices
Co-investorsBreakthrough VictoriaMedTech Actuator
Eden Brew develops food and supplementation products designed to deliver nutrition in natural forms that align with how the human body processes nutrients, with a focus on sustainable scaling and long-term health support.
BiotechDeep TechFoodTechHealthtechImpact & Social Good
Co-investorsBreakthrough VictoriaMain Sequence VenturesDigitalis VenturesPossible Ventures
Fable makes plant-based meat alternatives from shiitake mushrooms, using stems grown on hardwood logs that are sun-dried, boiled, shredded, and mixed with natural ingredients to create a whole-food center-of-plate protein.
Circular EconomyClimate TechConsumerFoodTech
Jim Fuller(Co-Founder & CSO)inMichael Fox(Co-Founder)in
Co-investorsAera VCBetter Bite VenturesBlackbird VenturesFPVK3 VenturesK3V Ventures+2 more
FUL Foods produces FUL BLU, a natural blue extract derived from spirulina microalgae containing phycocyanin, engineered for heat and pH stability across food, beverage, supplement, cosmetic and pharmaceutical applications.
Climate TechFoodTechNew Materials
Sara Guaglio(Co-Founder)in
Co-investorsFlying Fox VenturesMandalay Venture PartnersSHIFT Invest
Marama Labs develops optical spectroscopy instruments for life-sciences research, leveraging surface-enhanced Raman spectroscopy and nanoparticle characterization technology.
BiotechDeep TechHardwareHealthtechDublin, IE
Eric Le Ru(Founder)inBrendan Darby(Co-founder & CEO)inMatthias Meyer(Co-founder)in
Co-investorsBooster Innovation FundNZ Growth Capital PartnersNZVCQuidnet VenturesWNT VenturesIcehouse Ventures+2 more
Nourish Ingredients uses precision fermentation and lipid biotechnology to make animal-free fats and flavor ingredients, including Tastilux (a meaty phospholipid flavor) and Creamilux (a dairy emulsifier), for use in alternative meat and plant-based or hybrid dairy products.
BiotechFoodTech
James Petrie(CEO & Founder)inAnna El Tahchy(CTO & Founder Director)in
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology.
Deep TechHealthtechMedical DevicesPerth, AU
Co-investorsBrandon BioCatalyst
OpenStar develops compact fusion energy technology using a levitated dipole approach and high-temperature superconducting systems, working toward commercial fusion.
CleantechDeep TechEnergyWellington, NZ
Ratu Mataira(Founder & CEO)inThomas Berry(Co-founder & Chief Product Officer)inDarren Garnier(Chief Science Officer)inRod Badcock(Chief Technology Officer)inNicole Ferguson(VP - Finance)inBen Taylor-Bryant(VP - Investor Relations)in
Co-investorsBlackbird FoundryBlackbird VenturesIcehouse VenturesNZ Growth Capital PartnersOutset Ventures
Outset is a New Zealand-based deep tech venture firm and R&D campus that helps founders build and scale frontier technology companies globally, providing facilities, community, and capital.
Deep Tech
Mat Rowe(Founder)inMat R.(Founder)in
Co-investorsNZ Growth Capital Partners
Psychoactive is a global digital design and development agency specialising in high-performance websites, immersive digital experiences, and AI-era web platforms for ambitious brands.
AI & Machine LearningCreator EconomyDeveloper ToolsMarketing TechSaaSWellington, NZ
Andrew Hillstead(Creative Director & Producer)in
Tetratherix develops a biostealth fluid matrix built on its Tetramatrix platform technology to create regenerative medicine therapies, solutions, and products.
BiotechHealthtechMedical Devices
Treble is a venture capital firm founded by Daniel Gulati that invests in consumer technology startups at the earliest stage.
Consumer
Co-investorsSiesta VenturesEICEuropean Innovation Council FundFrumtak VenturesKOMPAS VCPaladin Capital Group
Wilder World is a blockchain-based open-world simulation game featuring the virtual city of Wiami, where players engage in racing, combat, missions, and asset ownership within a fully onchain economy.
Crypto & Web3Gaming
Co-investorsD1 VenturesDigital Currency GroupGenblock CapitalLD CapitalRed Beard VenturesSignum Capital+1 more
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches.
BiotechDeep TechDigital HealthHealthtechSydney, AU
Joshua Ismin(Co-founder, President)inDr. Sam Banister(Co-founder, Chief Scientific Officer)
Co-investorsPalo Santo VCTenmileXEIA Venture PartnersCapitalTCommon MagicSure Valley Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BetterbiteTurnto
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.